1.Correlation between perioperative blood transfusion and postoperative infections following coronary artery bypass grafting
Yiying TANG ; Ruirui SANG ; Yang LI ; Ruiming RONG ; Yining NIE ; Zaiyuan WEI ; Rong ZHOU
Chinese Journal of Blood Transfusion 2025;38(9):1177-1182
Objective: To explore the correlation between allogeneic red blood cell (RBC) transfusion and healthcare-associated infections (HAIs) in patients undergoing coronary artery bypass grafting (CABG) during the perioperative period. Methods: A single-center retrospective cohort of 1,170 patients undergoing isolated CABG was analyzed. Multivariable logistic regression and restricted cubic splines (RCS) were employed to explore the nonlinear association between perioperative RBC transfusion (from intraoperative period to 72 hours postoperatively) and HAIs. Results: Among the 1,170 CABG patients, 109 patients (9.2%) received RBC transfusion during the operation or within 3 days after the operation. The risk of HAIs in those who received ≥4 units of RBCs during and within 3 days after the operation was 6.89 times higher than that in the non-transfusion group (95% CI: 3.65-17.20). Furthermore, there was a nonlinear threshold effect between the blood transfusion volume and postoperative HAIs (inflection point: 7.8 units). When the transfusion volume was ≤7.8 units, the risk of HAIs increased by 61% for each additional unit transfused (OR=1.61, 95% CI: 1.21-2.15). Beyond this threshold, no statistically significant association was observed (P=0.289). Conclusion: Perioperative RBC transfusion in CABG patients is associated with an increased incidence of HAIs. The perioperative blood transfusion volume has a curvilinear relationship with the risk of postoperative HAIs. When the blood transfusion volume is ≤7.8 units, the blood transfusion volume has a dose-dependent relationship with postoperative infection, with higher blood transfusion volumes correlating with greater postoperative infection risk. When the blood transfusion volume is >7.8 units, the relationship between the two is not statistically significant. The preventive effect of reducing RBC transfusion on HAIs requires further validation in the future.
2.Influence of juxtapapillary duodenal diverticula on bile microecology in patients with primary common bile duct stones
Mengying WANG ; Hongtao HOU ; Wei SANG
Journal of Clinical Hepatology 2025;41(9):1868-1876
ObjectiveTo investigate the microbiological characteristics of bile in patients with common bile duct stones alone or comorbid with juxtapapillary duodenal diverticula (JPDD). MethodsA prospective study was conducted among 30 patients with common bile duct stones who were admitted to Department of Gastroenterology, Hebei General Hospital, from January to May 2024, and according to the presence or absence of JPDD, they were divided into JPDD group and simple common bile duct stones group (CBD group), with 15 patients in each group. Bile samples were collected during endoscopic retrograde cholangiopancreatography, and 16S rRNA microbial sequencing was performed to compare the differences in microbial composition, diversity, and metabolic pathways between the two groups. The independent-samples t test was used for comparison of normally distributed continuous data between two groups, and the Mann-Whitney U rank sum test was used for comparison of non-normally distributed continuous data between two groups; the chi-square test or the Fisher’s exact test was used for comparison of categorical data between two groups. Pearson correlation analysis or Spearman correlation analysis was used to analyze the correlation between clinical indicators and microbial species abundance. ResultsClinical data showed that compared with the CBD group, the JPDD group had significantly greater maximum diameter of stones (10.87±3.42 mm vs 6.80±2.08 mm, t=3.94, P0.01) and common bile duct diameter (14.73±3.95 mm vs 9.67±2.64 mm, t=4.13, P0.01). The microbiological analysis of the bile showed that Proteobacteria, Bacteroidetes, Firmicutes, and Actinobacteria were the most common phyla in both groups, and Proteobacteria was the dominate phylum in the JPDD group. At the genus and species levels, the JPDD group had higher relative abundances of Escherichia-Shigella, Enterococcus, and Escherichia coli. Alpha diversity was similar between the two groups, and there was a significant difference in beta diversity between the two groups (Adonis test, P0.05). The LEfSe analysis identified 25 differentially expressed species (LDA2) between the two groups, and the JPDD group had enrichment of 7 flora such as Enterobacter, Enterococcaceae, and Klebsiella, while the CBD group had significant enrichment of 18 flora such as Peptococcaceae, Roseburia, and Alistipes (P0.05). The correlation analysis showed that Enterococcaceae and Enterococcus significantly enriched in the JPDD group were positively correlated with the diameter of the common bile duct and the maximum diameter of stones (P0.01), whereas Peptococcaceae, Acinetobacter, and Alistipes with reductions in expression were negatively correlated with the diameter of the common bile duct and the maximum diameter of stones (P0.05). The enrichment analysis of biliary microbial metabolic pathways showed that there were significant differences between the two groups in 10 metabolic pathways such as cell growth and death, transportation and decomposition, nervous system, biosynthesis of valine, leucine, and isoleucine, and histidine metabolism (P0.05). ConclusionThe presence of JPDD may lead to alterations in bile microbiota, such as an increase in Enterococcus and a reduction in Roseburia, and specific flora and metabolism can promote the formation of common bile duct stones.
3.Clinical trial of Morinda officinalis oligosaccharides in the continuation treatment of adults with mild and moderate depression
Shu-Zhe ZHOU ; Zu-Cheng HAN ; Xiu-Zhen WANG ; Yan-Qing CHEN ; Ya-Ling HU ; Xue-Qin YU ; Bin-Hong WANG ; Guo-Zhen FAN ; Hong SANG ; Ying HAI ; Zhi-Jie JIA ; Zhan-Min WANG ; Yan WEI ; Jian-Guo ZHU ; Xue-Qin SONG ; Zhi-Dong LIU ; Li KUANG ; Hong-Ming WANG ; Feng TIAN ; Yu-Xin LI ; Ling ZHANG ; Hai LIN ; Bin WU ; Chao-Ying WANG ; Chang LIU ; Jia-Fan SUN ; Shao-Xiao YAN ; Jun LIU ; Shou-Fu XIE ; Mao-Sheng FANG ; Wei-Feng MI ; Hong-Yan ZHANG
The Chinese Journal of Clinical Pharmacology 2024;40(6):815-819
Objective To observe the efficacy and safety of Morinda officinalis oligosaccharides in the continuation treatment of mild and moderate depression.Methods An open,single-arm,multi-center design was adopted in our study.Adult patients with mild and moderate depression who had received acute treatment of Morinda officinalis oligosaccharides were enrolled and continue to receive Morinda officinalis oligosaccharides capsules for 24 weeks,the dose remained unchanged during continuation treatment.The remission rate,recurrence rate,recurrence time,and the change from baseline to endpoint of Hamilton Depression Scale(HAMD),Hamilton Anxiety Scale(HAMA),Clinical Global Impression-Severity(CGI-S)and Arizona Sexual Experience Scale(ASEX)were evaluated.The incidence of treatment-related adverse events was reported.Results The scores of HAMD-17 at baseline and after treatment were 6.60±1.87 and 5.85±4.18,scores of HAMA were 6.36±3.02 and 4.93±3.09,scores of CGI-S were 1.49±0.56 and 1.29±0.81,scores of ASEX were 15.92±4.72 and 15.57±5.26,with significant difference(P<0.05).After continuation treatment,the remission rate was 54.59%(202 cases/370 cases),and the recurrence rate was 6.49%(24 cases/370 cases),the recurrence time was(64.67±42.47)days.The incidence of treatment-related adverse events was 15.35%(64 cases/417 cases).Conclusion Morinda officinalis oligosaccharides capsules can be effectively used for the continuation treatment of mild and moderate depression,and are well tolerated and safe.
4.Predictive value of controlling nutritional status score in the prognosis of patients with advanced diffuse large B-cell lymphoma
Huirong SHAN ; Xicheng CHEN ; Hao ZHANG ; Yuqing MIAO ; Fei WANG ; Yuye SHI ; Ling WANG ; Jingjing YE ; Ziyuan SHEN ; Wei SANG ; Hongfeng GE
Journal of Leukemia & Lymphoma 2024;33(2):104-109
Objective:To investigate the predictive value of controlling nutritional status (CONUT) score in the prognosis of patients with advanced diffuse large B-cell lymphoma (DLBCL).Methods:A retrospective case series study was performed. The clinical data of 654 patients newly diagnosed with advanced DLBCL diagnosed in 7 medical centers in Huaihai Lymphoma Working Group from October 2009 to January 2022 were retrospectively collected. All the patients received rituximab-based immune chemotherapy regimens. The patients were randomly assigned to the training set (458 cases) and the validation set (196 cases) in a 7:3 ratio. The clinicopathological data of patients were collected, and the CONUT score was calculated based on albumin, lymphocyte count, and total cholesterol. The optimal critical value of CONUT scote was determined by using MaxStat method. Kaplan-Meier method was used to draw survival curves; Cox proportional hazards model was used to make univariate analysis and multivariate analysis on the factors influencing overall survival (OS). The efficacy of CONUT score in combination with the International prognostic index (IPI) and an enhanced IPI (NCCN-IPI) in predicting OS was evaluated by using receiver operating characteristic (ROC) curves.Results:The median follow-up time of 654 patients was 38.1 months (95% CI: 35.3 months- 40.9 months), and the 5-year OS rate was 49.2%. According to the MaxStat method, the optimal critical value for CONUT score was determined to be 6 points. All the patients were classified into the normal nutritional status group (CONUT score ≤ 6 points, 489 cases) and the poor nutritional status group (CONUT score > 6 points, 165 cases). The results of the multivariate analysis showed that CONUT score > 6 points, male, lactate dehydrogenase >240 U/L, high white blood cell count, low hemoglobin level and age > 60 years were independent risk factors for OS of patients with advanced DLBCL (all P < 0.05). Patients in the poor nutritional status group (CONUT score > 6 points) had worse OS compared with that in the normal nutritional status group in the overall cohort of advanced DLBCL. Subgroup analysis revealed that among patients with Eastern Cooperative Oncology Group-performance status (ECOG PS) score < 2 points, IPI low-intermediate risk, IPI intermediate-high risk, NCCN-IPI low-intermediate risk, and NCCN-IPI intermediate-high risk, the patients in the poor nutritional status group (CONUT score > 6 points) had worse OS compared with that in the normal nutritional status group (CONUT score ≤ 6 points) (all P < 0.05). Conclusions:CONUT score has a certain value in the assessment of the prognosis of patients with advanced DLBCL, and its predictive efficacy is further improved when combined with IPI and NCCN-IPI.
5.Oral anti-coagulants use in Chinese hospitalized patients with atrial fibrillation
Jing LIN ; Deyong LONG ; Chenxi JIANG ; Caihua SANG ; Ribo TANG ; Songnan LI ; Wei WANG ; Xueyuan GUO ; Man NING ; Zhaoqing SUN ; Na YANG ; Yongchen HAO ; Jun LIU ; Jing LIU ; Xin DU ; Louise MORGAN ; C. Gregg FONAROW ; C. Sidney SMITH ; Y.H. Gregory LIP ; Dong ZHAO ; Jianzeng DONG ; Changsheng MA
Chinese Medical Journal 2024;137(2):172-180
Background::Oral anti-coagulants (OAC) are the intervention for the prevention of stroke, which consistently improve clinical outcomes and survival among patients with atrial fibrillation (AF). The main purpose of this study is to identify problems in OAC utilization among hospitalized patients with AF in China.Methods::Using data from the Improving Care for Cardiovascular Disease in China-Atrial Fibrillation (CCC-AF) registry, guideline-recommended OAC use in eligible patients was assessed.Results::A total of 52,530 patients with non-valvular AF were enrolled from February 2015 to December 2019, of whom 38,203 were at a high risk of stroke, 9717 were at a moderate risk, and 4610 were at a low risk. On admission, only 20.0% (6075/30,420) of patients with a diagnosed AF and a high risk of stroke were taking OAC. The use of pre-hospital OAC on admission was associated with a lower risk of new-onset ischemic stroke/transient ischemic attack among the diagnosed AF population (adjusted odds ratio: 0.54, 95% confidence interval: 0.43–0.68; P <0.001). At discharge, the prescription rate of OAC was 45.2% (16,757/37,087) in eligible patients with high stroke risk and 60.7% (2778/4578) in eligible patients with low stroke risk. OAC utilization in patients with high stroke risk on admission or at discharge both increased largely over time (all P <0.001). Multivariate analysis showed that OAC utilization at discharge was positively associated with in-hospital rhythm control strategies, including catheter ablation (adjusted odds ratio [OR] 11.63, 95% confidence interval [CI] 10.04–13.47; P <0.001), electronic cardioversion (adjusted OR 2.41, 95% CI 1.65–3.51; P <0.001), and anti-arrhythmic drug use (adjusted OR 1.45, 95% CI 1.38–1.53; P <0.001). Conclusions::In hospitals participated in the CCC-AF project, >70% of AF patients were at a high risk of stroke. Although poor performance on guideline-recommended OAC use was found in this study, over time the CCC-AF project has made progress in stroke prevention in the Chinese AF population.Registration::ClinicalTrials.gov, NCT02309398.
6.Early experience with mechanical hemodynamic support for catheter ablation of malignant ventricular tachycardia
Mengmeng LI ; Yang YANG ; Deyong LONG ; Chenxi JIANG ; Ribo TANG ; Caihua SANG ; Wei WANG ; Xin ZHAO ; Xueyuan GUO ; Songnan LI ; Changyi LI ; Man NING ; Changqi JIA ; Li FENG ; Dan WEN ; Hui ZHU ; Yuexin JIANG ; Fang LIU ; Tong LIU ; Jianzeng DONG ; Changsheng MA
Chinese Journal of Cardiology 2024;52(7):768-776
Objective:To explore the role of mechanical hemodynamic support (MHS) in mapping and catheter ablation of patients with hemodynamically unstable ventricular tachycardia (VT), report single-center experience in a cohort of consecutive patients receiving VT ablation during MHS therapy, and provide evidence-based medical evidence for clinical practice.Methods:This was a retrospective cohort study. Patients with hemodynamically unstable VT who underwent catheter ablation with MHS at Beijing Anzhen Hospital, Capital Medical University between August 2021 and December 2023 were included. Patients were divided into rescue group and preventive group according to the purpose of treatment. Their demographic data, periprocedural details, and clinical outcomes were collected and analyzed.Results:A total of 15 patients with hemodynamically unstable VT were included (8 patients in the rescue group and 7 patients in the preventive group). The acute procedure was successful in all patients. One patient in the rescue group had surgical left ventricular assist device (LVAD) implantation, remaining 14 patients received extracorporeal membrane oxygenation (ECMO) for circulation support. ECMO decannulation was performed in 12 patients due to clinical and hemodynamic stability, of which 6 patients were decannulation immediately after surgery and the remaining patients were decannulation at 2.0 (2.5) d after surgery. Two patients in the rescue group died during the index admission due to refractory heart failure and cerebral hemorrhage. During a median follow-up of 30 d (1 d to 12 months), one patient with LVAD had one episode of ventricular fibrillation at 6 months after discharge, and no further episodes of ventricular fibrillation and/or VT occurred after treatment with antiarrhythmic drugs. No malignant ventricular arrhythmia occurred in the remaining 12 patients who were followed up.Conclusions:MHS contributes to the successful completion of mapping and catheter ablation in patients with hemodynamically unstable VT, providing desirable hemodynamic status for emergency and elective conditions.
7.Protection for military personnel in foreign countries
Yingxin ZOU ; Wenjuan SANG ; Li MA ; Wei CHEN
Military Medical Sciences 2024;48(5):321-324
The special operational environment of the military is likely to cause sunburn among troops.Through literature review and retrieval of information,the current methods for sunburn protection and support capacity of foreign armies were surveyed,involving ideas about of protection,major concerns and advantages so as to provide reference for generating and improving the ability of China's military to protect against sunburn.Foreign armies have attached importance to sunburn protection in special operating environments.China is to learn from the experience of foreign countries,make the troops better-informed of sunburn protection,improve the accessibility of the ready-made products for sunburn protection among the troops,and promote the research and development of sunscreen equipment and preparations for troops operating in extreme special environments.
8.The relationship between adipokines Apelin, adiponectin, Vaspin and susceptibility to coronary atherosclerotic heart disease in the aged and their effects on the severity of coronary lesions
Xi HONG ; Wei LIU ; Hengjun SANG
Chinese Journal of Postgraduates of Medicine 2024;47(8):746-750
Objective:To investigate the relationship between adipokines Apelin, adiponectin, Vaspin and susceptibility to coronary atherosclerotic heart disease (CHD) in the aged and their influence on the degree of coronary lesions.Methods:A total of 120 elderly patients with CHD admitted to Huozhou Coal and Power General Hospital from June 2022 to June 2023 were retrospectively selected(CHD group), and 120 elderly healthy physical examination subjects without CHD were selected as the control group in a 1:1 ratio. Baseline data, the levels of Apelin, adiponectin and Vaspin of the two groups were compared. Logistic regression was used to analyze the related factors of CHD susceptibility, and the levels of Apelin, adiponectin and Vaspin in patients with different CHD types, stenosis degree and number of lesions were compared. Spearman test was used to analyze the correlation between Apelin, adiponectin and Vaspin with stenosis degree and number of lesions.Results:The levels of Apelin, adiponectin and Vaspin in the CHD group were lower than those in the control group: (70.02 ± 13.54) ng/L vs. (86.75 ± 7.40) ng/L, (2.03 ± 0.67) μg/L vs. (2.80 ± 0.29) μg/L, (1.02 ± 0.31) μg/L vs. (2.10 ± 0.28) μg/L, there were statistical differences ( P<0.05). The Logistic regression equation was as follows: Logit ( P) = 2.953+1.401 × triglyceride + 1.446× low-density lipoprotein -0.761× Apelin -0.892 × adiponectin - 0.847 ×Vaspin, each coefficient had statistical significance ( P<0.05), it was suggested that with the increase of triglyceride and low-density lipoprotein levels and the decrease of Apelin, adiponectin and Vaspin levels, the susceptibility to CHD was gradually increased ( P<0.05). The levels of Apelin, adiponectin and Vaspin in patients with stable angina pectoris, unstable angina pectoris and acute myocardial infarction were decreased successively ( P<0.05). The levels of Apelin, adiponectin and Vaspin in patients with mild, moderate and severe stenosis were decreased successively ( P<0.05). The levels of Apelin, adiponectin and Vaspin in patients with single, double, 3 or more branches were decreased successively ( P<0.05). The results of Spearman test showed that Apelin, adiponectin and Vaspin were negatively correlated with the degree of stenosis ( r = - 0.728, - 0.808, - 0.779, P<0.05) and the number of lesions ( r = - 0.686, - 0.773, - 0.717, P<0.05). Conclusions:Apelin, adiponectin, and Vaspin are associated with the susceptibility of elderly people to CHD, and all three are negatively correlated with the severity of CHD stenosis and the number of diseased vessels. They are expected to become biomarkers for the onset and severity of CHD, providing a target idea for the prevention and treatment of CHD.
9.Effect of AIDS and tuberculosis co-infection on CD8+T lymphocytes
Jingmin NIE ; Xiang DU ; Yuanyuan YU ; Li TIAN ; Jun SANG ; Wei SUN
Chinese Journal of Infection and Chemotherapy 2024;24(4):390-394
Objective To investigate the effects of AIDS and tuberculosis(TB)co-infection on CD8+T lymphocytes.Methods Serum CD8+T cells and CD4+T cells were analyzed and compared between human immunodeficiency virus(HIV)alone patients(n=200),TB alone patients(n=200),and HIV/TB co-infection patients(n=200).Results CD8+T cells were significantly higher in HIV alone group compared to HIV/TB co-infection group and TB alone group(x2=128.779,P<0.001).The level of CD8+T lymphocytes in HIV/TB co-infection group and HIV alone group was higher than normal level(ZHIV/TB=8.343,PHIV/TB<0.001,ZHIV=7.988,PHIV<0.001).The CD8+T cells in TB alone group decreased significantly compared with normal levels(ZTB=8.682,PTB<0.001).The levels of CD4+T cells in the three groups of patients were all lower than normal(ZHIV=11.088,PHIV<0.001,ZTB=5.562,PTB<0.001,ZHIV/TB=12.077,PHIV/TB<0.001).The stratified analysis of CD8+T cell levels by CD4+T cell counts,showed that when CD4+T cell count was≤100 cells/μL,the level of CD8+T cells in HIV alone group was higher than that in TB alone group.HIV alone group had higher CD8+T cells than HIV/TB co-infection group,and the level of CD8+T cells in HIV/TB co-infection group was significantly lower than normal(Z0-100=1.604,P0-100=0.109).When CD4+T cells ≥101 cells/μL,HIV/TB co-infection group had higher CD8+T cells than TB alone group.HIV alone group had higher CD8+T cells than TB alone group.When CD4+T cells>500 cells/μL,CD8+T cell levels were within the normal range in all three groups of patients.Taking the HIV alone group as a reference,with the decrease of CD4+T cell count,the CD8+T cell count decreased more significantly in TB alone group and HIV/TB co-infection group than in HIV alone group(slope was 0.344 and 0.216,respectively,P<0.001).Conclusions With the decline of CD4+T cells,both HIV/TB co-infection and TB alone are associated with decrease in CD8+T cells,and the decrease in the TB alone group is more prominent.
10.Influencing factors of the therapeutic effect of PD-1 inhibitor pembrolizumab on cervical cancer
Jinghua HU ; Xuemei SANG ; Wei QIAO ; Miao ZHANG
China Pharmacist 2024;27(8):1375-1382
Objective To explore the influencing factors of the efficacy of programmed death-1(PD-1)inhibitor pembrolizumab in the treatment of cervical cancer.Methods The clinical data of cervical cancer patients admitted to the Department of Obstetrics and Gynecology of Anhui Women and Children's Medical Center from January 2020 to October 2023 were retrospectively analyzed and the patients were divided into the ineffective group and the effective group according to the pembrolizumab treatment efficacy.The clinical data of patients in the two groups were compared[age,tumor type,pathological type,lesion size,differentiation degree,number of pregnancies,number of births,number of miscarriages,menopausal status,tumor mutation load(TMB),DNA repair gene mutation status,PD-L1 expression,diabetes mellitus,hypertension,mode of treatment,body mass index,tumor-infiltrating lymphocyte(TIL)expression,neoantigen intra-tumor heterogeneity(ITH)status,presence of liver disease,and family history],and logistic regression analysis was used to determine the risk factors affecting the efficacy of pembrolizumab in cervical cancer patients.Results A total of 60 patients were included in the study,with 42 in the effective group and 18 in the ineffective group.The proportion of patients with TMB<143/Mb,no mutation in DNA repair genes,low expression of PD-L1,simple immunotherapy,TIL negative,and high PTH in the ineffective group was higher than that in the effective group(P<0.05).Multivariate Logistic regression analysis showed that TMB<143/Mb,non-mutated DNA repair genes,low PD-L1 expression,simple immunotherapy,TIL negative,and high PTH were risk factors affecting the efficacy of pembrolizumab in cervical cancer patients(P<0.05).Conclusion The efficacy of the PD-1 inhibitor pembrolizumab in cervical cancer patients is influenced by factors such as TMB,DNA gene mutations,PD-L1 expression,treatment mode,TIL,and ETH.

Result Analysis
Print
Save
E-mail